Member Info for potnak

I genuinely don't care if traders dip in and out. It can stay at 0.8 until it doesn't and it multi bags. I believe I bought at that last real bottom and have a lovely average of 0.74. Can see this being 5p in the next couple of months. So the traders can fill their boots. GLA DYOR

And if CHK1 is good. TYK2 goes up in value and that's where the big rerate will come from.

Well, I actually meant the CRT fund. Sareum only own 27% of the rights to chk1. It would make no sense to buy SAR out when they can develop the drug and still reap the rewards for much cheaper. The best case scenario as I see it is a milestone for chk1, which is due anyway in my opinion and a decent upfront for TYK2 cancer with Big backend milestones. The rest of the money will be use to drive chk1 home and get TYK2 into clinics. They could, of course, surprise all here and in licence something from another company completely. Time will tell.

Yep, why take over SAR when they can develop the drugs under licence for a fraction of what they could be worth. Think a lot here are forgetting that SRI own more of CHK1 than Sar do. No point just buying part of it.

For what it's worth. My prediction is. A nice milestone for chk1 and a back loaded licence deal for TYK2. May see us rerate to 3p.

Sierra would need to raise again, if that was the case. Think we are getting ahead of ourselves here.

I'm enjoying reading all the posts. The change of advisor and the Sierra raise have certainly added a sense of positivity to this board. I'm not getting excited until the fat lady is actually singing though. As Thoth said, we've been here before. I'd be happy with a milestone for starters.

They do already have money. Would we accept $200mil I think that's too cheap! I'd want $200 mil just for CHK1. In all seriousness, this raise can only be good news for SAR.

Thanks, Zylo - So they don't need 200mil for PII then. So is the rest for licensing TYK2 I wonder. Bit dodgy putting all your eggs in one basket but if the science works, why not.

they don't need 200mil to get CHK1 through PII, do they? if not, Thoth may be correct. Be nice to get a big upfront for TYK2.

Milestone imminently inbound!!

My money is on a 'conflict of interest' so they've moved into an advisory role.

In my experience, middle of the year without a specific date would mean June or July.

Middle of the year is the end of June. 6 months done - 6 months to go.

Utar. Literally, the first thing I thought was institutional investors. Which companies are also on WH books? Getting ready for work so can't check.

At the very least, we might start seeing WH clients buying in here now.

I don't think so Num. This is just one of those things that's needs to be done before a deal is done. It will all come out in the wash.

Mr Sherlock Thoth will find a link. But I see this change as a solution to some conflict of interest somewhere. Interesting. I'm excited about this but I don't know why.

The placing will come in Nov as usual. Unless we have a milestone by then.

Maybe the II's are finally coming?